MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Non-motor Scales"

  • MDS Virtual Congress 2021

    Strategies for Social Prescribing: Combating Loneliness in Parkinson’s Disease

    I. Subramanian, J. Farahnik, L. Mischley (Los Angeles, USA)

    Objective: To examine the association between online social engagement (SE) including exercise & support groups, phone calls/video chats and daily outings with motor and non-motor…
  • MDS Virtual Congress 2021

    CLE-600: Treating nocturnal and early morning OFF symptomology in Parkinson’s disease with the OLAR® platform

    E. Berkovich (Petch-Tikva, Israel)

    Objective: Development of a treatment for nocturnal and early morning OFF symptomology in Parkinson’s disease. Background: Levodopa Parkinson’s disease (PD) treatment is limited by its…
  • MDS Virtual Congress 2021

    Data-driven prediction of fatigue in Parkinson’s disease patients

    DG. Lee, M. Mirian, L. Adrian, A. Yu, S. Neilson, K. Sundvick, E. Golz, L. Folger, S. Appel-Cresswell (Vancouver, Canada)

    Objective: The overall aim of this study is to identify which items of the Fatigue Severity Scale (FSS) best predict clinically significant fatigue in male…
  • MDS Virtual Congress 2021

    The Gastrointestinal Dysfunction Scale – Parkinson’s Disease (GIDS-PD): a new tool to assess gastrointestinal dysfunction in Parkinson’s Disease

    M. Camacho, J. Greenland, C. Williams-Gray (Cambridge, United Kingdom)

    Objective: Objective: To develop and validate the Gastrointestinal Dysfunction Scale – Parkinson’s Disease (GIDS-PD), a self-report scale designed to assess presence and severity of Gastrointestinal…
  • MDS Virtual Congress 2021

    Safinamide Improves Pain in Parkinson´s Disease. Results from the SAFINONMOTOR Study.

    R. Yáñez, C. Labandeira, M. Cimas Hernando, I. Cabo, J. Paz González, M. Alonso Losada, M. González Palmás, C. Martínez, D. Santos García (Ourense, Spain)

    Objective: Our aim was to analyze the effectiveness of safinamide on pain in Parkinson´s disease (PD) patients from the SAFINONMOTOR (an open-label study of the…
  • MDS Virtual Congress 2021

    Obstructive sleep apnea and other vascular risk factors’ impact on Non-motor Symptoms in Parkinson’s Disease

    B. Meira, M. Fernandes, M. Salavisa, M. Saraiva, L. Conceiçao, C. Borbinha, F. Ladeira, JP. Marto, R. Barbosa, M. Mendonça, P. Bugalho (Lisbon, Portugal)

    Objective: To investigate the relationship between vascular comorbidity and non-motor symptoms in Parkinson’s Disease (PD) patients. Background: Previous studies suggested a significant association between the…
  • MDS Virtual Congress 2021

    The satisfaction with life and treatment scale (SLTS-7) in patients with Parkinson’s disease

    A. Sauerbier, P. Bachon, L. Ambrosio, P. Leohrer, A. Rizos, S. Jost, A. Gronostay, A. Konitsioti, M. Barbe, G. Fink, K. Ashkan, C. Nimsky, V. Visser-Vandewalle, K. Ray Chaudhuri, L. Timmermann, P. Martinez-Martin, H. Dafsari (Köln, Germany)

    Objective: To explore a new rating tool to assess satisfaction with life and treatment (SLTS-7) in a PD population. Background: The satisfaction with life and in…
  • MDS Virtual Congress 2021

    Fatigue in patients with progressive supranuclear palsy

    JH. Ahn, J. Song, I. Choi, DY. Lee, J. Youn, JW. Cho (Seoul, Republic of Korea)

    Objective: To investigate prevalence and clinical impact of fatigue in the patients with progressive supranuclear palsy Background: Fatigue is a common and disabling non-motor symptom…
  • MDS Virtual Congress 2021

    Physical activity (PA), patient reported outcomes and quality of life in Parkinson’s disease( PD)

    J. Morley, I. Subramanian, J. Farahnik, L. Mischley (Philadelphia, USA)

    Objective: To examine the association between PA, motor and non-motor symptoms (NMS) and quality of life (QoL) in PD using a validated web-based survey Background:…
  • MDS Virtual Congress 2021

    Gender bias in patients with Parkinson’s disease undergoing subthalamic stimulation

    S. Jost, L. Strobel, A. Rizos, P. Loehrer, K. Ashkan, J. Evans, F. Rosenkranz, M. Barbe, G. Fink, J. Franklin, A. Sauerbier, C. Nimsky, A. Sattari, K. Ray Chaudhuri, A. Antonini, L. Timmermann, P. Martinez-Martin, M. Silverdale, E. Kalbe, V. Visser-Vandewalle, H. Dafsari (Cologne, Germany)

    Objective: To investigate whether there is a gender bias in patients with Parkinson’s disease (PD) undergoing deep brain stimulation (DBS) at a single health system…
  • « Previous Page
  • 1
  • …
  • 21
  • 22
  • 23
  • 24
  • 25
  • …
  • 55
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley